Corpus Intelligence IC Memo — HOOD RIVER MEMORIAL HOSPITAL 2026-04-26 15:56 UTC
IC Memo — HOOD RIVER MEMORIAL HOSPITAL
Investment Committee Memorandum | OR | 25 beds | Grade B | EBITDA uplift $8.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HOOD RIVER MEMORIAL HOSPITAL

CCN 381318 | nan, OR | 25 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

HOOD RIVER MEMORIAL HOSPITAL is a 25-bed suburban community hospital in nan, OR with $113.0M in net patient revenue and a -11.6% operating margin. The hospital serves a payer mix of 38.7% Medicare, 2.8% Medicaid, and 58.5% commercial.

Thesis: Turnaround. Our ML models identify $8.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -11.6% to -4.3% (+736bps).

Net Revenue HCRIS$113.0M
Current EBITDA COMPUTED$-13.1M
Operating Margin COMPUTED-11.6%
Occupancy HCRIS56.4%
Revenue / Bed COMPUTED$4.5M
Net-to-Gross HCRIS50.8%
Distress Probability ML44.0%

2. Market Context & Competitive Position

63
OR Hospitals
-8.1%
State Median Margin
34
Comparable Hospitals

OR has 63 Medicare-certified hospitals with a median operating margin of -8.1%. The target's margin of -11.6% places it below the state median. Among 34 size-comparable peers (12-50 beds), the median margin is -5.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 34 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HOOD RIVER MEMORIAL HOSPITAL (Target)OR25$113.0M-11.6%
GOOD SHEPHERD MEDICAL CENTEROR25$177.5M5.3%
COLUMBIA MEMORIAL HOSPITALOR25$165.9M5.2%
SAMARITAN LEBANON COMM HOSPITAOR25$157.9M3.9%
PROVIDENCE NEWBERG MEDICAL CENOR40$151.5M10.0%
SAMARITAN PACIFIC COMM HOSPITAOR25$141.7M3.7%
GRANDE RONDE HOSPITALOR25$134.8M-4.1%
PROVIDENCE MILWAUKIE HOSPITALOR40$128.8M-9.6%
MID-COLUMBIA MEDICAL CENTEROR44$123.2M-20.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.4M+210bp18mo
Cost to Collect4.5%2.5%$2.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.4M+122bp9mo
Clean Claim Rate88.0%96.0%$72K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.4M
Cost to Collect
$2.3M
Denial Rate Reduction
$2.2M
A/R Days Reduction
$1.4M
Clean Claim Rate
$72K
Total EBITDA Uplift$8.3M
Current EBITDA$-13.1M
+ RCM Uplift+$8.3M
Pro Forma EBITDA$-4.8M
Current Margin-11.6%
Pro Forma Margin-4.3%
WC Released (1x)$4.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-20.2M$-3.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-20.2M$-10.3M0.00x-100.0%
Bull Case9.0x11.0x$-18.2M$10.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-18.2M$6.2M0.00x-100.0%
Bear Case11.0x10.0x$-22.2M$-38.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-22.2M$-49.5M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 34 hospitals with 12-50 beds
  • Same-state prioritization (n=35)
  • Comp margins: P25=-15.5% / P50=-5.8% / P75=3.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.